A

Affect Therapeutics

Digital addiction treatment with contingency management

Family Nurse Practitioner - Telehealth Substance Use Disorder

Full-Time
No salary listed
Junior, Mid
Remote in USA
RemoteMust hold an active, unrestricted Ohio license. The role may include periodic internal team meetings.
Medical, Clinical & VeterinaryAdvanced Practice Providers

About the job

Requirements
  • Hold an active, verifiable Family Nurse Practitioner license in the state or states where you practice and in your state of residence if it is not Ohio; the Ohio license must be active and unrestricted.
  • Have at least two years of experience; relevant prior experience may be considered for candidates with less than two years as a Family Nurse Practitioner.
  • Have experience prescribing Suboxone and active Drug Enforcement Administration registration.
  • Be willing to obtain multi-state licensure; the cost is covered by Affect.
  • Have empathy for members facing behavioral health challenges.
  • Be comfortable using technology, including electronic health records and mobile applications.
  • Have a quiet, private office and reliable internet connection for HIPAA-compliant telehealth visits.
Responsibilities
  • Conduct initial and follow-up telehealth evaluations.
  • Deliver care for substance use disorders.
  • Prescribe medications as appropriate and answer member questions.
  • Complete documentation in the Healthie electronic health record.
  • Collaborate with the care team and attend occasional scheduled team meetings.
Desired Qualifications
  • Medicaid enrollment is a plus.
  • Addiction experience is ideal.

About the company

Affect Therapeutics provides digital addiction recovery services that combine contingency management with therapy and medication. The platform is private, fully online, and accessible via secure video conferencing, removing the need to visit clinics. It uses financial incentives to reward healthy behaviors, helping users build new habits, and offers holistic support such as job search, housing guidance, and bill management to improve overall life circumstances. The business likely operates on a subscription or fee-for-service model to fund ongoing treatment and support. Compared to traditional clinics, the service emphasizes digital convenience, privacy, and integrated life-support, aiming to help people recover from addiction and improve their broader daily life.

Company Size

51-200

Company Stage

Series B

Total Funding

$49M

Headquarters

Tysons, Virginia

Founded

2020

Get referred to Affect Therapeutics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Affect raised $26 million on September 23, 2025 to expand nationally.
  • Its app was updated August 27, 2026 and still advertises Medicare and Medicaid coverage.
  • Affect says it serves over 100 employer, Medicaid, marketplace, and Medicare Advantage plans.

What critics are saying

  • If CMS or states tighten contingency-management reimbursement, Affect's payer model breaks.
  • Commercial insurers can delay contracting; without renewals, growth stalls by 2027.
  • Privacy breaches or low patient retention would undermine trust and trigger rapid member churn.

What makes Affect Therapeutics unique

  • Affect combines contingency management, therapy, and medication in one smartphone clinic.
  • It operates in 20 states and accepts Medicare, Medicaid, and commercial insurance.
  • NIH-backed research and 2025 Series B validation support its clinical model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Remote Work Options
  • Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

2%

2 year growth

1%
Behavioral Health Business
Nov 5th, 2025
Affect Therapeutics Raises $26M Funding

Affect Therapeutics, a digital mental health and addiction treatment provider, has raised $26M in a Series B funding round led by Allumia Ventures. The company offers therapy, medical support, and a gamified app for conditions like depression, PTSD, anxiety, OCD, and substance use disorders. It operates in several U.S. states and accepts major insurance plans. Previously, Affect Therapeutics raised $23M, including a $16M Series A in 2023.

Crunchbase
Jul 13th, 2023
Affect raises $16M as addiction-related financings hold strong

Affect Therapeutics, a provider of all-digital addiction treatment programs, raised $16 million in a Series A round led by Artis Ventures.

FinSMEs
Jul 12th, 2023
Affect Therapeutics Raises $16M In Series A Funding

Affect Therapeutics, a McLean, VA-based company providing addiction treatment for the digital age, raised $16M in Series A funding.The round was led by ARTIS Ventures with additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures. Stuart Peterson of ARTIS Ventures has joined the Board, and Dr. Imran Hamid of LifeArc Ventures joined the Board as an observer. The company intends to use the funds to enable national expansion, program expansion, and engineering innovation in the Affect app.Founded in 2020, Affect Therapeutics offers clinically intensive treatment that follows a scientifically-proven program supporting the entire recovery journey via a smartphone app for drug and alcohol addiction. The approach, based on the best research in the field including its own NIH-sponsored studies, combines experts at unlocking behavior change and motivation, with members receiving rewards for success in treatment, including engagement and provision of negative drug and alcohol screens. The company’s approach couples this type of cognitive behavioral therapy with counseling, medical oversight, and case management, delivering a comprehensive program based on decades of research.Affect currently holds outpatient treatment licenses in 20 states and aims to serve a majority of the U.S. population by the end of 2023

Yahoo Finance
Jul 12th, 2023
Delivering Next generation Addiction recovery, Affect Therapeutics raises $16 million in Series A funding led by ARTIS Ventures

Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by TechBio-focused ARTIS Ventures with additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures.

TechCrunch
Apr 21st, 2021
Affect raises a seed round to grow its stimulant abuse recovery service

There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech, and sometimes even a space startup. But amid the regular flow of funding news, it’s still rare to come across a company raising money to take on addiction with software. So when Affect’s $1 million seed round from AlleyCorp came to my attention, I wanted to learn a bit more.